Product Information
SILDENAFIL 10 MG/ML ORAL SUSP is a generic product labeled by Actavis Pharma, Inc., priced at $0.2603 per ML under NDC 00591405094. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on May 29, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Actavis Pharma, Inc.NDC
00591405094
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SILDENAFIL CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211534FDA Approved
5/29/2020
TE Code
AB
On Market Since
8/17/2020
Pharmacological Classes
Price Statistics
The NADAC for SILDENAFIL 10 MG/ML ORAL SUSP has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 67.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2603 per ML |
|---|---|
| All-time high | $0.7945 (May 15, 2024) |
| All-time low | $0.2603 (Sep 23, 2026) |
| 52-week high | $0.6121 |
| 52-week low | $0.2603 |
| Median price | $0.6121 |
| Average price | $0.5651 |
| Largest weekly change | -13.9% (Aug 19, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sildenafil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SILDENAFIL 10 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SILDENAFIL 10 MG/ML ORAL SUSP, manufactured by Actavis Pharma, Inc., is $0.2603 per ML (NDC 00591405094), effective Sep 30, 2026.
How has the price of SILDENAFIL 10 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for SILDENAFIL 10 MG/ML ORAL SUSP has declined 67.2%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SILDENAFIL 10 MG/ML ORAL SUSP?
Since Apr 17, 2024, the NADAC for SILDENAFIL 10 MG/ML ORAL SUSP has ranged from a low of $0.2603 (Sep 23, 2026) to a high of $0.7945 (May 15, 2024), with a median of $0.6121 per ML.
Are there cheaper alternatives to SILDENAFIL 10 MG/ML ORAL SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SILDENAFIL 10 MG/ML ORAL SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures SILDENAFIL 10 MG/ML ORAL SUSP?
SILDENAFIL 10 MG/ML ORAL SUSP (NDC 00591405094) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.